Reckitt Benckiser Unveils Pricing for Tender Offer Related to Mead Johnson Nutrition Notes

Reckitt Benckiser Announces Tender Offer Pricing Details

In a recent announcement from Reckitt Benckiser Group plc, the company outlined the pricing terms of its cash tender offer concerning the 4.600% Senior Notes issued by its subsidiary, Mead Johnson Nutrition Company (MJN), that are due in 2044. This move is significantly noteworthy for stakeholders and investors as it provides transparency and clarity regarding the company's financial maneuvers.

Overview of the Tender Offer

The cash tender offer aims to purchase all outstanding 4.600% Senior Notes maturing in 2044. Along with the tender offer, MJN is conducting a solicitation for consents from registered holders of these notes. The proposed amendments include key changes like the elimination of most restrictive covenants and certain events of default, along with the release of Reckitt's guarantee on these notes.

The details regarding the pricing have been carefully outlined in the Offer to Purchase and Consent Solicitation Statement dated August 5, 2026 (the Statement). Notably, the total consideration for each $1,000 of principal amount of notes that are validly tendered prior to the Expiration Time on August 13, 2026, has been set at $898.00, in addition to accrued interest.

Important Dates and Terms

The tender offer and consent solicitation are set to expire at 5:00 p.m. New York time on the specified date, allowing a window for noteholders to submit their consents. Holders who validly tender their notes and accompany them with consents may also revoke their submissions prior to the deadline, which adds a layer of flexibility for the investors.

The expected settlement date for this transaction is August 18, 2026, subject to any extensions or changes that MJN may decide to implement. However, to keep in mind, the completion of this tender offer is conditioned upon certain specified criteria being met.

Implications of the Proposed Amendments

Should the proposed amendments gain sufficient consents from holders of more than half of the outstanding notes, the amendments will be implemented by way of a supplemental indenture. This would generalize a shift in MJN’s obligations regarding the notes while significantly lowering restrictions tied to their management.

It's vital for investors to understand that even if the tender offer completes successfully, any notes not tendered will continue to be active and governed by the existing indenture terms. Essentially, MJN will still hold responsibility for the scheduled interest and principal payments on these retained notes.

The Role of Financial Advisors

The Dealer Managers for this tender offer, Deutsche Bank Securities Inc. and Merrill Lynch International, stand prepared to assist investors and answer questions about the tender process. Global Bondholder Services Corporation has also been appointed as the tender and information agent, ensuring a seamless communication as the process unfolds.

Conclusion

This tender offer represents a strategic move by Reckitt’s subsidiary to streamline its financial obligations while granting investors an opportunity to adjust their holdings in response to coming changes. Stakeholders are encouraged to review the Statement and consult financial advisors to navigate this development effectively. It emphasizes the company's commitment to transparency and proactive financial management, which appears to be at the heart of Reckitt Benckiser’s operational ethos and future trajectory.

For more information regarding Reckitt, MJN, and detailed updates on the tender offer, potential investors may visit Reckitt’s investor relations page or contact the designated dealer managers directly.